MA52870A - Peptides ayant une activité inhibitrice sur le récepteur muscarinique m3 - Google Patents

Peptides ayant une activité inhibitrice sur le récepteur muscarinique m3

Info

Publication number
MA52870A
MA52870A MA052870A MA52870A MA52870A MA 52870 A MA52870 A MA 52870A MA 052870 A MA052870 A MA 052870A MA 52870 A MA52870 A MA 52870A MA 52870 A MA52870 A MA 52870A
Authority
MA
Morocco
Prior art keywords
inhibitoral
muscarinic
peptides
receptor
activity
Prior art date
Application number
MA052870A
Other languages
English (en)
Inventor
Cristina Bartella
Giner Isabel Devesa
Ballester Gregorio Fernandez
Montiel Antonio Ferrer
Francesca Mancini
Giorgina Mangano
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of MA52870A publication Critical patent/MA52870A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cosmetics (AREA)
MA052870A 2018-06-13 2019-06-11 Peptides ayant une activité inhibitrice sur le récepteur muscarinique m3 MA52870A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP18177587 2018-06-13

Publications (1)

Publication Number Publication Date
MA52870A true MA52870A (fr) 2021-04-21

Family

ID=62636028

Family Applications (1)

Application Number Title Priority Date Filing Date
MA052870A MA52870A (fr) 2018-06-13 2019-06-11 Peptides ayant une activité inhibitrice sur le récepteur muscarinique m3

Country Status (6)

Country Link
US (1) US12102705B2 (fr)
EP (1) EP3807294A1 (fr)
JP (2) JP7523358B2 (fr)
EA (1) EA202190018A1 (fr)
MA (1) MA52870A (fr)
WO (1) WO2019238686A1 (fr)

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998045322A2 (fr) * 1997-04-10 1998-10-15 Royal Netherlands Academy Of Arts And Sciences Reactifs pour diagnostics et procede correspondant
US6559128B1 (en) * 2000-01-21 2003-05-06 Northwestern University Inhibitors of G protein-mediated signaling, methods of making them, and uses thereof
EP1295939A4 (fr) 2000-06-15 2005-02-02 Kyowa Hakko Kogyo Kk Proteine de liaison de facteur de croissance insulinoide
US8568766B2 (en) 2000-08-24 2013-10-29 Gattadahalli M. Anantharamaiah Peptides and peptide mimetics to treat pathologies associated with eye disease
US20020086036A1 (en) 2000-12-05 2002-07-04 Allergan Sales, Inc. Methods for treating hyperhidrosis
AU2002360353A1 (en) 2001-12-11 2003-06-23 University Of Iowa Research Foundation Receptor-targeted adenoviral vectors
US20050282755A1 (en) 2004-03-18 2005-12-22 Ansata Therapeutics, Inc. Compositions having antimicrobial activity and uses thereof
WO2005118647A2 (fr) 2004-05-18 2005-12-15 Genentech, Inc. Principaux variants de proteines de coque pour affichage c-terminal et bi-terminal
WO2007048022A2 (fr) 2005-10-21 2007-04-26 Alexion Pharmaceuticals, Inc. Prroteines de fusion anticorps-polypeptide et methodes de production et d'utilisation
EP2071334A1 (fr) 2007-12-14 2009-06-17 Transmedi SA Compositions et procédés pour la détection de TIABS
CN102037014A (zh) 2008-03-12 2011-04-27 奥塔哥创新有限公司 生物标记物
WO2013040142A2 (fr) * 2011-09-16 2013-03-21 Iogenetics, Llc Procédés bio-informatiques de détermination de liaisons peptidiques
JPWO2013125221A1 (ja) 2012-02-21 2015-07-30 静岡県 抗体精製用アフィニティリガンド
BR112014022855A2 (pt) 2012-03-16 2017-07-18 Regeneron Pharma animal não humano geneticamente modificado, mamífero geneticamente modificado, e, método para fabricar um animal não humano
MX356343B (es) 2012-04-13 2018-05-23 Lubrizol Advanced Mat Inc Compuestos que inhiben la exocitosis neuronal (ii).
WO2013172926A1 (fr) * 2012-05-14 2013-11-21 Yale University Biomarqueurs immunes et analyses pour prévoir la réponse clinique à une immunothéraphie contre le cancer
JP2015522264A (ja) 2012-06-26 2015-08-06 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 細胞透過性ペプチドおよび細胞透過性ペプチドを同定する方法
WO2014200910A2 (fr) * 2013-06-10 2014-12-18 Iogenetics, Llc Procédés bio-informatiques de détermination de liaisons peptidiques
CN108513593A (zh) 2015-04-23 2018-09-07 南托米克斯有限责任公司 癌症新表位
IL260296B2 (en) * 2016-01-04 2024-01-01 Cour Pharmaceuticals Dev Company Inc Particles thermalize fusion proteins containing associated epitopes
WO2018223092A1 (fr) * 2017-06-02 2018-12-06 Arizona Board Of Regents On Behalf Of Arizona State University Procédé de création de vaccins anticancéreux personnalisés

Also Published As

Publication number Publication date
US12102705B2 (en) 2024-10-01
JP2024045275A (ja) 2024-04-02
US20220142898A1 (en) 2022-05-12
WO2019238686A1 (fr) 2019-12-19
EP3807294A1 (fr) 2021-04-21
EA202190018A1 (ru) 2021-03-17
JP7523358B2 (ja) 2024-07-26
JP2021528390A (ja) 2021-10-21

Similar Documents

Publication Publication Date Title
CL2019000234S1 (es) Vehículo.
MA52366A (fr) Anticorps anti-tl1a optimisés
CL2019000361S1 (es) Escobilla.
DK3840144T3 (da) Skifteanordningen
MA52870A (fr) Peptides ayant une activité inhibitrice sur le récepteur muscarinique m3
MA52869A (fr) Peptides ayant une activité inhibitrice sur l'exocytose neuronale
MA52588A (fr) Macrocyclase peptidique
CL2018002256S1 (es) Vehículo.
CL2018002259S1 (es) Vehículo.
UA39020S (uk) Пенал для ванної кімнати
UA38321S (uk) Сумка-килимок для пляжу
ES1224679Y (es) Asiento multifunción
CL2019002573S1 (es) Pintalabios.
IT201900023247A1 (it) Dispositivo di seduta
CL2019003096S1 (es) Mochila.
CL2019003097S1 (es) Mochila.
UA38095S (uk) Ергономічне сидіння для транспортного засобу
UA38094S (uk) Ергономічне сидіння для транспортного засобу
UA38093S (uk) Ергономічне сидіння для транспортного засобу
ES1227109Y (es) Asiento ergonomico
CL2019000905S1 (es) Mochila.
CL2019000001S1 (es) Apoya cabeza.
UA39446S (uk) Саморіз для покрівлі
UA39502S (uk) Саморіз для покрівлі
UA38591S (uk) Термос